Product image of Icomas (Methane, Acetylene, Carbon Monoxide) supplied by GNH India

Icomas

Active Ingredient:
Methane, Acetylene, Carbon Monoxide
Origin:
EU

Icomas (Methane, Acetylene, Carbon Monoxide)

Methane, Acetylene, Carbon Monoxide, the active ingredients in Icomas, are a gaseous blend presented as an inhalation‑type formulation for inhalation use. This mixture is classified under gas products and does not have an approved therapeutic class or specific disease indication in the European market. It is primarily managed under industrial and research safety regulations rather than conventional pharmaceutical dosing.

GNH India supplies Icomas as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and research institutions across multiple regions worldwide.

Manufacturer / TM Owner

Linde Sverige Ab

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Icomas does not have recognized therapeutic indications; therefore no clinical uses are listed.

  • Research and development: Utilized as a test gas for studying combustion and toxicology.
  • Analytical calibration: Employed to calibrate gas detection instruments and sensors.
  • Industrial safety training: Used in controlled environments for training on gas handling procedures.

How It Works

  • The components of Icomas interact with biological systems primarily through their physical and chemical properties. Methane and acetylene are largely inert under normal conditions, while carbon monoxide binds to hemoglobin with high affinity, reducing oxygen transport. The overall effect of the mixture depends on the concentration of each gas and the duration of exposure.

Side Effects

Icomas may cause a range of adverse reactions when inhaled, varying with concentration and exposure time.

Common Side Effects

  • Headache
  • Dizziness
  • Nausea
  • Light‑headedness
  • Shortness of breath
  • Fatigue

Serious or Rare Side Effects

  • Loss of consciousness
  • Carbon monoxide poisoning
  • Cardiac arrhythmia
  • Severe respiratory depression
  • Methemoglobinemia
  • Neurological impairment

Precautions & Warnings

Safe handling of Icomas requires strict adherence to occupational and environmental guidelines.

  • Avoid exposure: Limit inhalation to controlled environments.
  • Use protective equipment: Wear appropriate respiratory protection.
  • Monitor concentration: Use gas detectors to ensure levels remain below occupational limits.
  • Ventilation: Ensure adequate airflow in areas where the gas is used.
  • Medical supervision: Individuals with cardiovascular or respiratory disease should be evaluated before exposure.
  • Store at ambient temperature: Keep cylinders in a well‑ventilated, cool area away from ignition sources.

Avoid Interactions

Icomas can interact with other gases or medical interventions, potentially altering safety profiles.

Major Interactions (Avoid)

  • Oxygen therapy: High concentrations may displace oxygen, leading to hypoxia.
  • Nitrogen oxides: May increase formation of toxic compounds.
  • Smoking: Increases risk of carbon monoxide toxicity.

Moderate Interactions (Monitor Closely)

  • Anesthetic agents: May potentiate respiratory depression.
  • Anticoagulants: No direct effect but monitor if bleeding risk is present.
  • Medications affecting hemoglobin affinity: May alter carbon monoxide binding.

Frequently Asked Questions

Icomas is a gaseous blend of methane, acetylene and carbon monoxide supplied primarily for industrial, research and analytical applications rather than for approved therapeutic treatment. It is used in controlled laboratory settings for calibration of detection equipment, combustion studies, and safety training.

The three gases act through their physical and chemical properties. Methane and acetylene are combustible gases used to study flame behavior, while carbon monoxide binds to hemoglobin, reducing oxygen transport. The overall effect depends on concentration and exposure time, influencing physiological responses in experimental models.

The dosage of Icomas is not defined for medical therapy. The amount used is determined by the specific research protocol, calibration requirement or safety training scenario, and must be set by the responsible professional in accordance with applicable safety standards and regulatory limits.

Because Icomas contains carbon monoxide, a known toxic gas, it is not considered safe for use by pregnant or breastfeeding individuals. Exposure could impair oxygen delivery to the fetus or infant, and therefore it should be avoided unless a qualified risk assessment justifies controlled use.

To place an order, submit an enquiry on the Icomas product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

The closest alternative is a standard calibration gas mixture containing nitrogen, oxygen and carbon monoxide. Compared with such mixtures, Icomas includes combustible components (methane and acetylene) which make it suitable for combustion and flame‑propagation studies, whereas typical calibration gases focus solely on non‑combustible components for sensor verification.

Icomas should be stored at ambient temperature, preferably below 25 °C, in a well‑ventilated, dry area away from heat sources and open flames. Cylinders must be secured upright, protected from physical damage, and handled with appropriate respiratory protection and gas‑detection equipment.

Icomas is administered by inhalation from a pressurized gas cylinder using a regulator and delivery system designed for gaseous substances. The flow rate and exposure duration are controlled by the operator to meet the specific experimental or training protocol, and continuous monitoring of gas concentrations is essential.

The most serious risks include carbon monoxide poisoning, which can cause loss of consciousness, cardiac arrhythmias, and neurological damage, as well as fire or explosion hazards from the combustible methane and acetylene components. Immediate medical attention is required if symptoms of hypoxia or toxicity appear.

Individuals with pre‑existing cardiovascular or respiratory conditions, pregnant or nursing persons, and anyone lacking proper training in gas handling should not use Icomas. Additionally, it should not be used in settings without adequate ventilation, gas detection, and emergency response measures.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.